Translational Control: Discovery and Mechanisms
翻译控制:发现和机制
基本信息
- 批准号:10623926
- 负责人:
- 金额:$ 64.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisAntibioticsBacteriaBacterial InfectionsBiochemicalBrainCell NucleusCellular StressComplexCryoelectron MicroscopyDiseaseEnvironmentEukaryotaGene ExpressionGeneticGenetic DiseasesGenetic TranscriptionHumanIn VitroLearningMessenger RNAMethodsMolecularMovementNeuronal PlasticityNeuronsNonsense CodonPathway interactionsPositioning AttributeProcessProtein BiosynthesisProteinsProteomeResolutionRibosomal InteractionRibosomesStressSynapsesSynaptic plasticityTimeTranscriptional RegulationTranslational RegulationTranslationsVisualizationbiological adaptation to stressmemory consolidationnervous system disorderneurodevelopmentnovelprematuretherapeutic developmenttranslation factor
项目摘要
Andrei A. Korostelev
ABSTRACT
Ribosomes are a central hub for controlling gene expression. They not only synthesize proteins, but also regulate
bacterial stress responses, human neurodevelopment and synaptic plasticity. Understanding how ribosomes
control gene expression requires high-resolution structural and accurate biochemical characterization of
ribosome dynamics and interactions, both in vitro and in complex cellular environments. We are uniquely
positioned to address these key challenges by investigating the following questions:
How do ribosomes regulate bacterial stress responses? In bacteria, ribosomes sense cellular stress via
several pathways, which control the transcriptional adaptation to stress. The direct and indirect pathways that
couple translation with transcription are promising antibiotic targets. We will dissect the structural and cellular
mechanisms of using novel biochemical approaches and ensemble cryo-EM.
How do ribosomes sense functional and dysfunctional mRNAs? Translation is a major pathway for
sensing problematic mRNAs in eukaryotes, and dysregulation of stress-response mechanisms leads to disease.
To determine how the ribosome recognizes dysfunctional mRNAs with premature nonsense codons, we will use
cellular, biochemical and structural (time-resolved cryo-EM) methods to visualize ribosome interactions with
problematic mRNAs.
How does translation regulate neurodevelopment and neuroplasticity and contribute to neurological
disorders? Translation regulation in neurons is essential for neurodevelopment, memory consolidation, and
learning, whereas translation dysregulation drives neurological diseases, such as amyotrophic lateral sclerosis.
The synaptic proteome—far from the nucleus—is controlled by local translation and requires brain-specific
translation factors and auxiliary proteins. To elucidate the molecular mechanisms of neuronal translation
regulation, we will use genetic, biochemical, and structural approaches, including cellular EM at Ångström-level
detail in functional neurons.
安德烈·A·科罗斯捷列夫
抽象的
核糖体是控制基因表达的中心枢纽。它们不仅合成蛋白质,而且还调节
细菌应激反应、人类神经发育和突触可塑性。了解核糖体如何
控制基因表达需要高分辨率的结构和准确的生化特征
体外和复杂细胞环境中的核糖体动力学和相互作用。我们是独一无二的
通过调查以下问题来应对这些关键挑战:
核糖体如何调节细菌应激反应?在细菌中,核糖体通过以下方式感知细胞压力
控制转录适应应激的多种途径。直接和间接途径
翻译与转录的结合是有希望的抗生素靶点。我们将剖析结构和细胞
使用新型生化方法和整体冷冻电镜的机制。
核糖体如何感知功能性和功能失调的 mRNA?翻译是主要途径
感知真核生物中有问题的 mRNA,应激反应机制的失调会导致疾病。
为了确定核糖体如何识别带有过早无义密码子的功能失调的 mRNA,我们将使用
细胞、生化和结构(时间分辨冷冻电镜)方法可视化核糖体与
有问题的 mRNA。
翻译如何调节神经发育和神经可塑性并有助于神经学
失调?神经元的翻译调节对于神经发育、记忆巩固和
学习,而翻译失调会导致神经系统疾病,例如肌萎缩侧索硬化症。
突触蛋白质组远离细胞核,由局部翻译控制,需要大脑特异性
翻译因子和辅助蛋白。阐明神经元翻译的分子机制
调节,我们将使用遗传、生化和结构方法,包括埃格斯特伦水平的细胞 EM
功能神经元的细节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrei Korostelev其他文献
Andrei Korostelev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrei Korostelev', 18)}}的其他基金
Molecular principles of stringent response activation in bacteria
细菌严格反应激活的分子原理
- 批准号:
10453921 - 财政年份:2021
- 资助金额:
$ 64.53万 - 项目类别:
Structural bases for cellular stress responses mediated by stalled translation
翻译停滞介导的细胞应激反应的结构基础
- 批准号:
8595445 - 财政年份:2013
- 资助金额:
$ 64.53万 - 项目类别:
Structural bases for cellular stress responses mediated by stalled translation
翻译停滞介导的细胞应激反应的结构基础
- 批准号:
8708911 - 财政年份:2013
- 资助金额:
$ 64.53万 - 项目类别:
Structural bases for cellular stress responses mediated by stalled translation
翻译停滞介导的细胞应激反应的结构基础
- 批准号:
8858644 - 财政年份:2013
- 资助金额:
$ 64.53万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 64.53万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 64.53万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 64.53万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 64.53万 - 项目类别:
Fellowship














{{item.name}}会员




